MVT-1075 / BioNTech  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MVT-1075 / BioNTech
NCT03118349: Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Radioimmunotherapy

Terminated
1
4
US
MVT-1075, 177Lu-CHX-A"-DTPA-HuMab-5B1, MVT-5873, HuMab-5B1
BioNTech Research & Development, Inc.
Pancreatic Carcinoma, Tumors That Express CA 19-9
04/18
04/18

Download Options